Navigation Links
NYBG launches Amazon Forest Program to help conserve Earth's largest intact forest
Date:2/2/2014

tate of Rondnia, where many of the Garden's Amazon Forest Program activities are currently focused. Rondnia's forests are severely threatened by soybean farming, cattle ranching, settlements, mining, and hydroelectric projects.

The Amazon phase of the National Forest Inventory will begin in Rondnia in 2014. The Garden is working with the Brazilian Forest Service, the regional environmental protection agency, and the Federal University of Rondnia to make Jamari National Forest in Rondnia a model of forest management for the Amazonian national forests where logging concessions will be granted. A pilot training course for mateiros has already been completed there. Also, the Garden has started a project in collaboration with institutions in Rondnia, neighboring Acre state, and Santa Cruz, Bolivia, to conduct a botanical inventory of Rondnia's border regions.

Program Leadership Builds on Decades of Research and Collaboration in the Amazon

Dr. Daly, the director of the Garden's Amazon Forest Program, has studied the flora of Amazonia for more than three decades, with a concentration on the Burseraceae (frankincense and myrrh family), one of the most difficult, diverse, and ecologically important Amazonian tree families. He has focused much of his work in the Brazilian state of Acre, where he has catalogued the flora and studied non-timber forest products to help diversify the regional forest economy.

By making his research program an indispensable source of information on the plant resources of southwestern Amazonia, Dr. Daly and his collaborators have advanced conservation and guided public policy.

They have participated directly in a state zoning project in Acre, providing justifications for the creation of new conservation units, and they are part of a tri-national consortium that is helping to monitor the impacts of a new highway linking Amazonia and the Pacific Ocean. Dr. Daly has worked closely with Brazilian col
'/>"/>

Contact: Stevenson Swanson
sswanson@nybg.org
718-817-8512
The New York Botanical Garden
Source:Eurekalert  

Page: 1 2 3 4 5 6

Related biology news :

1. Eurofins MWG Operon launches ion proton sequencing services with CSP certification
2. American Society for Microbiology launches science diplomacy magazine
3. Hoyos Labs, a Digital Infrastructure Security Company, Launches; Rethinks How We Authenticate and Secure Identity
4. Elsevier launches new open access journal: Photoacoustics
5. Bold new partnership launches to harness potential of data scientists and big data
6. CSHL launches bioRxiv, a freely accessible, citable preprint server for biology
7. Frontiers launches 2 new open-access journals: Frontiers in Earth Science and Frontiers in Environmental Science
8. Keystone Symposia launches 2013-14 meeting series with first conference in Rio de Janeiro
9. Fujitsu Launches Four Smartphones and Two Tablet PCs With FPC Embedded Fingerprint Technology for the Japanese Market
10. DNA SPECTRUM LAUNCHES GROUNDBREAKING DNA STORAGE PRODUCT
11. Babcock Genetics Launches Breed Select Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NYBG launches Amazon Forest Program to help conserve Earth's largest intact forest
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... UPTON, NY - A study at the U.S. Department of ... "tagged" with a radioactive form of carbon can be used ... estrogen, in the human brain. The research, published in the ... regions of the brain where aromatase is concentrated may be ...
... breakthrough by scientists at the University of Sheffield has shed ... the land over 470 million years ago by forming a ... today (2 November 2010) in Nature Communications , has ... worked together with soil-dwelling fungi to ,green, the Earth in ...
... 2010 CONRAD, leaders in reproductive health and HIV prevention ... Agency for International Development (USAID). The grant will fund ... also prevent HIV and STI infections. USAID ... conducted by the Centre for Programme Research for AIDS in ...
Cached Biology News:PET scans reveal estrogen-producing hotspots in human brain 2Study shows how ancient plants and soil fungi turned the Earth green 2USAID awards $5 million to CONRAD 2
(Date:7/30/2015)... and Dallas, TX, USA (PRWEB) , ... July ... ... innovative nano and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. ... at executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development ...
(Date:7/30/2015)... , July 30, 2015   Aratana ... pet therapeutics company focused on the licensing, development ... animals, today announced that its strategic partner VetStem ... dose confirmation study of AT-016, an adipose-derived allogeneic ... the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Regional Cancer PatientsNEW ORLEANS, April 28 Ochsner Health ... Health Sciences Center , New Orleans ( www.lsuhsc.edu ... the region,s cancer patients by combining clinical care and ... and provide better access to care. This collaboration will ...
... could prove efficacious for both prophylactic and ... Corporation (NYSE AMEX: CVM ) ... that vaccines utilizing its proprietary L.E.A.P.S.(TM) (Ligand ... potentially induce protection against illnesses such as ...
... 28 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, announced today that results from a ... at the 12th Annual Conference on Vaccine Research, being ... is sponsored by the National Foundation of Infectious Diseases.David ...
Cached Biology Technology:Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 2PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 4PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 5PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 6PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 7
... KLH-conjugated, synthetic peptide corresponding to ... mouse p19ARF. The epitope ... 62-75. Clone 5-C3-1. Quality ... immunoblot. Stability ...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Complete cell culture media with cytokines...
...
Biology Products: